Entrada Therapeutics, Inc. (TRDA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.47 | -306.5% |
| 2024 | $1.68 | +940.0% |
| 2023 | $-0.20 | +93.4% |
| 2022 | $-3.02 | +63.0% |
| 2021 | $-8.16 | +66.0% |
| 2020 | $-24.00 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.47 | -306.5% |
| 2024 | $1.68 | +940.0% |
| 2023 | $-0.20 | +93.4% |
| 2022 | $-3.02 | +63.0% |
| 2021 | $-8.16 | +66.0% |
| 2020 | $-24.00 | — |